121 related articles for article (PubMed ID: 19264589)
1. Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity.
Salamon D; Banati F; Koroknai A; Ravasz M; Szenthe K; Bathori Z; Bakos A; Niller HH; Wolf H; Minarovits J
J Gen Virol; 2009 May; 90(Pt 5):1183-1189. PubMed ID: 19264589
[TBL] [Abstract][Full Text] [Related]
2. CTCF prevents the epigenetic drift of EBV latency promoter Qp.
Tempera I; Wiedmer A; Dheekollu J; Lieberman PM
PLoS Pathog; 2010 Aug; 6(8):e1001048. PubMed ID: 20730088
[TBL] [Abstract][Full Text] [Related]
3. Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency.
Hughes DJ; Marendy EM; Dickerson CA; Yetming KD; Sample CE; Sample JT
J Virol; 2012 Jan; 86(2):1034-45. PubMed ID: 22072770
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF.
Chau CM; Zhang XY; McMahon SB; Lieberman PM
J Virol; 2006 Jun; 80(12):5723-32. PubMed ID: 16731911
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.
Chen YJ; Chen YL; Chang Y; Wu CC; Ko YC; Tsao SW; Chen JY; Lin SF
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490592
[TBL] [Abstract][Full Text] [Related]
6. High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.
Bakos A; Banati F; Koroknai A; Takacs M; Salamon D; Minarovits-Kormuta S; Schwarzmann F; Wolf H; Niller HH; Minarovits J
Virus Genes; 2007 Oct; 35(2):195-202. PubMed ID: 17510783
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial.
Robertson KD; Hayward SD; Ling PD; Samid D; Ambinder RF
Mol Cell Biol; 1995 Nov; 15(11):6150-9. PubMed ID: 7565767
[TBL] [Abstract][Full Text] [Related]
8. Occupancy of chromatin organizers in the Epstein-Barr virus genome.
Holdorf MM; Cooper SB; Yamamoto KR; Miranda JJ
Virology; 2011 Jun; 415(1):1-5. PubMed ID: 21550623
[TBL] [Abstract][Full Text] [Related]
9. The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive.
Tao Q; Robertson KD; Manns A; Hildesheim A; Ambinder RF
J Virol; 1998 Sep; 72(9):7075-83. PubMed ID: 9696800
[TBL] [Abstract][Full Text] [Related]
10. PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type.
Lupey-Green LN; Caruso LB; Madzo J; Martin KA; Tan Y; Hulse M; Tempera I
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976663
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency.
Schaefer BC; Paulson E; Strominger JL; Speck SH
Mol Cell Biol; 1997 Feb; 17(2):873-86. PubMed ID: 9001242
[TBL] [Abstract][Full Text] [Related]
12. CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.
Robertson KD; Manns A; Swinnen LJ; Zong JC; Gulley ML; Ambinder RF
Blood; 1996 Oct; 88(8):3129-36. PubMed ID: 8874213
[TBL] [Abstract][Full Text] [Related]
13. Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs.
Schaefer BC; Strominger JL; Speck SH
Mol Cell Biol; 1997 Jan; 17(1):364-77. PubMed ID: 8972217
[TBL] [Abstract][Full Text] [Related]
14. Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection.
Yoshioka M; Kikuta H; Ishiguro N; Ma X; Kobayashi K
J Gen Virol; 2003 May; 84(Pt 5):1133-1140. PubMed ID: 12692278
[TBL] [Abstract][Full Text] [Related]
15. Chromatin profiling of Epstein-Barr virus latency control region.
Day L; Chau CM; Nebozhyn M; Rennekamp AJ; Showe M; Lieberman PM
J Virol; 2007 Jun; 81(12):6389-401. PubMed ID: 17409162
[TBL] [Abstract][Full Text] [Related]
16. Heat shock factor 1 upregulates transcription of Epstein-Barr Virus nuclear antigen 1 by binding to a heat shock element within the BamHI-Q promoter.
Wang FW; Wu XR; Liu WJ; Liao YJ; Lin S; Zong YS; Zeng MS; Zeng YX; Mai SJ; Xie D
Virology; 2011 Dec; 421(2):184-91. PubMed ID: 22018489
[TBL] [Abstract][Full Text] [Related]
17. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of latent Epstein-Barr virus promoters.
Takacs M; Banati F; Koroknai A; Segesdi J; Salamon D; Wolf H; Niller HH; Minarovits J
Biochim Biophys Acta; 2010; 1799(3-4):228-35. PubMed ID: 19853674
[TBL] [Abstract][Full Text] [Related]
19. EBV latency types adopt alternative chromatin conformations.
Tempera I; Klichinsky M; Lieberman PM
PLoS Pathog; 2011 Jul; 7(7):e1002180. PubMed ID: 21829357
[TBL] [Abstract][Full Text] [Related]
20. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
Chen H; Lee JM; Wang Y; Huang DP; Ambinder RF; Hayward SD
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9339-44. PubMed ID: 10430944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
